INHIBITION OF PSEUDOMONAS-AERUGINOSA ELASTASE AND PSEUDOMONAS KERATITIS USING A THIOL-BASED PEPTIDE

被引:45
作者
BURNS, FR [1 ]
PATERSON, CA [1 ]
GRAY, RD [1 ]
WELLS, JT [1 ]
机构
[1] UNIV LOUISVILLE,SCH MED,DEPT BIOCHEM,LOUISVILLE,KY 40292
关键词
D O I
10.1128/AAC.34.11.2065
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa elastase is a zinc metalloproteinase which is released during P. aeruginosa infections. Pseudomonas keratitis, which occurs following contact lens-induced corneal trauma, can lead to rapid, liquefactive necrosis of the cornea. This destruction has been attributed to the release of both host-derived enzymes and the bacterial products P. aeruginosa elastase, alkaline protease, exotoxin A, and lipopolysaccharide endotoxin. A synthetic metalloproteinase inhibitor, HSCH2 (DL)CH[CH2CH(CH3)2]CO-Phe-Ala-NH2, which we previously showed to be a potent inhibitor of corneal collagenase and alkali-induced corneal ulceration, was tested as a potential inhibitor of P. aeruginosa elastase. Inhibition constants (K(i)s) for the resolved diastereomers were determined with the chromogenic substrate furylacryloyl-glycyl-L-leucyl-L-alanine. One isomer had a K(i) of 0.3 μM, while the other had a K(i) of 0.4 μM. The more potent diastereomer was evaluated in vivo in experimentally induced Pseudomonas keratitis in rabbits. Following inoculation of one cornea of each rabbit, topical treatment with a 1 mM solution of the inhibitor significantly delayed the onset of corneal melting and perforation, as compared with the results for the control and gentamicin-treated groups. This protective effect suggests that the inhibitor may have a therapeutic application by delaying the progression of corneal destruction in Pseudomonas keratitis.
引用
收藏
页码:2065 / 2069
页数:5
相关论文
共 32 条
[21]   INVITRO INHIBITION OF PSEUDOMONAS-AERUGINOSA ELASTASE BY METAL-CHELATING PEPTIDE DERIVATIVES [J].
KESSLER, E ;
ISRAEL, M ;
LANDSHMAN, N ;
CHECHICK, A ;
BLUMBERG, S .
INFECTION AND IMMUNITY, 1982, 38 (02) :716-723
[22]  
KESSLER E, 1977, INVEST OPHTH VIS SCI, V16, P116
[23]  
KESSLER E, 1977, INVEST OPHTH VIS SCI, V16, P488
[24]  
KREGER AS, 1986, INVEST OPHTH VIS SCI, V27, P932
[25]  
KREGER AS, 1978, INFECT IMMUN, V19, P630, DOI 10.1128/IAI.19.2.630-648.1978
[26]  
LAIBSON PR, 1972, ARCH OPHTHALMOL-CHIC, V88, P553
[27]  
LEVY J H, 1988, Investigative Ophthalmology and Visual Science, V29, P172
[28]  
Liesegang T.J., 1988, CORNEA, P217
[29]  
RAMPHAL R, 1981, ANN OPHTHALMOL, V13, P421
[30]  
SEEDOR JA, 1987, ARCH OPHTHALMOL-CHIC, V105, P268